EFNA2 and cancer: For example, EVs from senescent stromal cells can enhance the proliferation of cancer cells by promoting the activation of the ephrin-A2 tyrosine kinase receptor, which interacts with overexpressed ephrin-A1 on the surface of the cancer cells, thereby boosting an Erk-dependent proliferation pathway [110,113].